ISSN 2327-2236
Vol. 4, Issue 2, 2017June 09, 2016 EDT
The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
Articles in Vol. 4, Issue 2, 2017
Vol. 4, Issue 2, 2017
- Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United StatesSteven R. FeldmanAnders Holmen MoellerSandra T. Erntoft IdemyrJuan Marcos González
- The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare SystemLee SternYi-Chien LeeBiwen TaoLois LameratoGaurav GangoliRichard KocharianWalter Danker III
- Estimating the Burden of Cost in Chronic Graft-versus-Host Disease: A Human Capital ApproachChris A. JonesLuca P. FernandezPeter WeimersheimerNeil A. ZakaiMichael SharfOscar A. MesaChristian PetersAntonio di CarloMitchell C. Norotsky
- The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next DecadeChristopher A. JonesDavid G. ChapmanPeter WeimersheimerLuca FernandezOscar Alejandro MesaChristian PetersBart M. VanaudenaerdeMitchell C. NorotskyRobin Vos
- What Drives Responses to Willingness-to-pay Questions? A Methodological Inquiry in the Context of Hypertension Self-managementBillingsley KaambwaStirling BryanEmma FrewEmma BraySheila GreenfieldRichard J McManus
- Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative StudyNatalia HawkenZalmai HakimiSamuel AballéaJameel NazirIsaac A. O. OdeyemiMondher Toumi
- Mobile Integrated Healthcare: Preliminary Experience and Impact Analysis with a Medicare Advantage PopulationDaniel J. CastilloJ. Brent MyersJonathan MockoEric H. Beck
- A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaMargaret HuxDenise ZouEsprit MaPeter SajosiAndreas EngstromRoss SelbyEugene BensonAndrew BriggsVijayveer Bonthapally
1.
Jones CA, Chapman DG, Weimersheimer P, et al. The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade. JHEOR. 2016;4(2):119-126. doi:10.36469/9815
